Figure 4.
Alterations in urinary NAG (A) and KIM-1 (B) levels at the end of the study in non-diabetic control rats and in diabetic rats treated with vehicle, metformin, canagliflozin, metformin + canagliflozin, or quercetin for a period of 12 weeks. Data are presented as mean ± SEM. # p < 0.05 vs. non-diabetic control rats and * p < 0.05 vs. vehicle-treated diabetic rats.